...
机译:用南乌斯治疗胰腺癌患者的围手术期护理
Sun Yat Sen Univ Affiliated Hosp 1 Dept Med Ultrason Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Dept Med Ultrason Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Dept Med Ultrason Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Dept Med Ultrason Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Dept Liver Surg Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Dept Med Ultrason Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Dept Med Ultrason Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Dept Med Ultrason Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 1 Dept Med Ultrason Div Intervent Ultrasound Guangzhou 510080 Peoples R China;
Irreversible Electroporation Ablation; Pancreatic Adenocarcinoma; Perioperative Period; Nursing;
机译:用南乌斯治疗胰腺癌患者的围手术期护理
机译:术前抗癌治疗对胰腺癌可切除性和围手术期结局的影响:日本肝胆胰外科协会的研究项目。
机译:术前抗癌治疗对胰腺癌患者重新分配和围手术期结果的影响:日本肝胆胰腺外科学会的项目研究。
机译:临床护理途径在乳腺癌患者围手术期护理中的价值
机译:治疗慢性非癌症疼痛患者怀疑与护理经验的关系
机译:与新近行胰腺切除术相比新辅助立体定位放化疗治疗边缘型可切除胰腺癌的手术围手术期结局良好
机译:表5.5.a.1肿瘤大小和治疗(重新切性率)图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度,TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后,患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时,围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后,患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头